Report cover image

Genomics Market In US 2026-2030

Publisher TechNavio
Published Jan 12, 2026
Length 187 Pages
SKU # INF20708905

Description

Genomics Market In US 2026-2030

The genomics market in us is forecasted to grow by USD 9246.2 mn during 2025-2030, accelerating at a CAGR of 12.9% during the forecast period. The report on the genomics market in us provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by technological innovations in next generation sequencing and bioinformatics integration, increasing demand for creating and upgrading genome databases, integration of ai and ml in genomic data analysis.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's genomics market in us is segmented as below:

By Application
  • Diagnostics
  • Drug discovery
  • Others
By End-User
  • Hospitals and clinics
  • Academics and research institutes
  • Pharmaceuticals and biotechnology companies
  • Others
By Solution
  • Products
  • Services
Geography
  • North America
  • US
This study identifies the acceleration of precision medicine and targeted oncology clinical integration as one of the prime reasons driving the genomics market in us growth during the next few years. Also, advances in sequencing technologies and growing applications of genomics in oncology will lead to sizable demand in the market.

The report on the genomics market in us covers the following areas:
  • Genomics market in us sizing
  • Genomics market in us forecast
  • Genomics market in us industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading genomics market in us vendors that include Agilent Technologies Inc., Bio Rad Laboratories Inc., Caris Life Sciences, CENTOGENE NV, Danaher Corp., Eurofins Scientific SE, F. Hoffmann La Roche Ltd., Illumina Inc., LetsGetChecked, Myriad Genetics Inc., Natera Inc., Oxford Nanopore Technologies, Pacific Biosciences Inc., Personalis Inc., QIAGEN N.V., Revvity Inc., Thermo Fisher Scientific Inc., Twist Bioscience Corp.. Also, the genomics market in us analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

187 Pages
1 Executive Summary
1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Country Market Characteristics
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Market Segmentation by End-user
Executive Summary - Chart on Market Segmentation by Solution
Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
2 Technavio Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
3 Market Landscape
3.1 Market ecosystem
Chart on Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Chart on Market characteristics analysis
3.3 Value chain analysis
Chart on Value chain analysis
4 Market Sizing
4 Market Sizing
4.1 Market definition
Data Table on Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2025
4.4 Market outlook: Forecast for 2025-2030
Chart on US - Market size and forecast 2025-2030 ($ million)
Data Table on US - Market size and forecast 2025-2030 ($ million)
Chart on US: Year-over-year growth 2025-2030 (%)
Data Table on US: Year-over-year growth 2025-2030 (%)
5 Historic Market Size
5 Historic Market Size
5.1 Genomics Market in US 2020 - 2024
Historic Market Size - Data Table on Genomics Market in US 2020 - 2024 ($ million)
5.2 Application segment analysis 2020 - 2024
Historic Market Size - Application Segment 2020 - 2024 ($ million)
5.3 End-user segment analysis 2020 - 2024
Historic Market Size - End-user Segment 2020 - 2024 ($ million)
5.4 Solution segment analysis 2020 - 2024
Historic Market Size - Solution Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
6 Qualitative Analysis
6.1 The AI impact on Genomics Market in US
7 Five Forces Analysis
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2025 and 2030
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2025 and 2030
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2025 and 2030
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2025 and 2030
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2025 and 2030
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2025 and 2030
7.7 Market condition
Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Application
8 Market Segmentation by Application
8.1 Market segments
Chart on Application - Market share 2025-2030 (%)
Data Table on Application - Market share 2025-2030 (%)
8.2 Comparison by Application
Chart on Comparison by Application
Data Table on Comparison by Application
8.3 Diagnostics - Market size and forecast 2025-2030
Chart on Diagnostics - Market size and forecast 2025-2030 ($ million)
Data Table on Diagnostics - Market size and forecast 2025-2030 ($ million)
Chart on Diagnostics - Year-over-year growth 2025-2030 (%)
Data Table on Diagnostics - Year-over-year growth 2025-2030 (%)
8.4 Drug discovery - Market size and forecast 2025-2030
Chart on Drug discovery - Market size and forecast 2025-2030 ($ million)
Data Table on Drug discovery - Market size and forecast 2025-2030 ($ million)
Chart on Drug discovery - Year-over-year growth 2025-2030 (%)
Data Table on Drug discovery - Year-over-year growth 2025-2030 (%)
8.5 Others - Market size and forecast 2025-2030
Chart on Others - Market size and forecast 2025-2030 ($ million)
Data Table on Others - Market size and forecast 2025-2030 ($ million)
Chart on Others - Year-over-year growth 2025-2030 (%)
Data Table on Others - Year-over-year growth 2025-2030 (%)
8.6 Market opportunity by Application
Market opportunity by Application ($ million)
Data Table on Market opportunity by Application ($ million)
9 Market Segmentation by End-user
9 Market Segmentation by End-user
9.1 Market segments
Chart on End-user - Market share 2025-2030 (%)
Data Table on End-user - Market share 2025-2030 (%)
9.2 Comparison by End-user
Chart on Comparison by End-user
Data Table on Comparison by End-user
9.3 Hospitals and clinics - Market size and forecast 2025-2030
Chart on Hospitals and clinics - Market size and forecast 2025-2030 ($ million)
Data Table on Hospitals and clinics - Market size and forecast 2025-2030 ($ million)
Chart on Hospitals and clinics - Year-over-year growth 2025-2030 (%)
Data Table on Hospitals and clinics - Year-over-year growth 2025-2030 (%)
9.4 Academics and research institutes - Market size and forecast 2025-2030
Chart on Academics and research institutes - Market size and forecast 2025-2030 ($ million)
Data Table on Academics and research institutes - Market size and forecast 2025-2030 ($ million)
Chart on Academics and research institutes - Year-over-year growth 2025-2030 (%)
Data Table on Academics and research institutes - Year-over-year growth 2025-2030 (%)
9.5 Pharmaceuticals and biotechnology companies - Market size and forecast 2025-2030
Chart on Pharmaceuticals and biotechnology companies - Market size and forecast 2025-2030 ($ million)
Data Table on Pharmaceuticals and biotechnology companies - Market size and forecast 2025-2030 ($ million)
Chart on Pharmaceuticals and biotechnology companies - Year-over-year growth 2025-2030 (%)
Data Table on Pharmaceuticals and biotechnology companies - Year-over-year growth 2025-2030 (%)
9.6 Others - Market size and forecast 2025-2030
Chart on Others - Market size and forecast 2025-2030 ($ million)
Data Table on Others - Market size and forecast 2025-2030 ($ million)
Chart on Others - Year-over-year growth 2025-2030 (%)
Data Table on Others - Year-over-year growth 2025-2030 (%)
9.7 Market opportunity by End-user
Market opportunity by End-user ($ million)
Data Table on Market opportunity by End-user ($ million)
10 Market Segmentation by Solution
10 Market Segmentation by Solution
10.1 Market segments
Chart on Solution - Market share 2025-2030 (%)
Data Table on Solution - Market share 2025-2030 (%)
10.2 Comparison by Solution
Chart on Comparison by Solution
Data Table on Comparison by Solution
10.3 Products - Market size and forecast 2025-2030
Chart on Products - Market size and forecast 2025-2030 ($ million)
Data Table on Products - Market size and forecast 2025-2030 ($ million)
Chart on Products - Year-over-year growth 2025-2030 (%)
Data Table on Products - Year-over-year growth 2025-2030 (%)
10.4 Services - Market size and forecast 2025-2030
Chart on Services - Market size and forecast 2025-2030 ($ million)
Data Table on Services - Market size and forecast 2025-2030 ($ million)
Chart on Services - Year-over-year growth 2025-2030 (%)
Data Table on Services - Year-over-year growth 2025-2030 (%)
10.5 Market opportunity by Solution
Market opportunity by Solution ($ million)
Data Table on Market opportunity by Solution ($ million)
11 Customer Landscape
11 Customer Landscape
11.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Drivers, Challenges, and Opportunity
12 Drivers, Challenges, and Opportunity
12.1 Market drivers
Technological innovations in next generation sequencing and bioinformatics integration
Increasing demand for creating and upgrading genome databases
Integration of AI and ML in genomic data analysis
12.2 Market challenges
Data security and regulatory compliance issues
Reimbursement hurdles and economic disparities
Clinical integration and workforce shortages
12.3 Impact of drivers and challenges
Impact of drivers and challenges in 2025 and 2030
12.4 Market opportunities
Acceleration of precision medicine and targeted oncology clinical integration
Advances in sequencing technologies
Growing applications of genomics in oncology
13 Competitive Landscape
13 Competitive Landscape
13.1 Overview
13.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
13.3 Landscape disruption
Overview on factors of disruption
13.4 Industry risks
Impact of key risks on business
14 Competitive Analysis
14 Competitive Analysis
14.1 Companies profiled
Companies covered
14.2 Company ranking index
Company ranking index
14.3 Market positioning of companies
Matrix on companies position and classification
14.4 Agilent Technologies Inc.
Agilent Technologies Inc. - Overview
Agilent Technologies Inc. - Business segments
Agilent Technologies Inc. - Key news
Agilent Technologies Inc. - Key offerings
Agilent Technologies Inc. - Segment focus
SWOT
14.5 Bio Rad Laboratories Inc.
Bio Rad Laboratories Inc. - Overview
Bio Rad Laboratories Inc. - Business segments
Bio Rad Laboratories Inc. - Key news
Bio Rad Laboratories Inc. - Key offerings
Bio Rad Laboratories Inc. - Segment focus
SWOT
14.6 Danaher Corp.
Danaher Corp. - Overview
Danaher Corp. - Business segments
Danaher Corp. - Key news
Danaher Corp. - Key offerings
Danaher Corp. - Segment focus
SWOT
14.7 Eurofins Scientific SE
Eurofins Scientific SE - Overview
Eurofins Scientific SE - Business segments
Eurofins Scientific SE - Key offerings
Eurofins Scientific SE - Segment focus
SWOT
14.8 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
SWOT
14.9 Illumina Inc.
Illumina Inc. - Overview
Illumina Inc. - Business segments
Illumina Inc. - Key news
Illumina Inc. - Key offerings
Illumina Inc. - Segment focus
SWOT
14.10 LetsGetChecked
LetsGetChecked - Overview
LetsGetChecked - Product / Service
LetsGetChecked - Key offerings
SWOT
14.11 Myriad Genetics Inc.
Myriad Genetics Inc. - Overview
Myriad Genetics Inc. - Product / Service
Myriad Genetics Inc. - Key news
Myriad Genetics Inc. - Key offerings
SWOT
14.12 Natera Inc.
Natera Inc. - Overview
Natera Inc. - Product / Service
Natera Inc. - Key news
Natera Inc. - Key offerings
SWOT
14.13 Oxford Nanopore Technologies
Oxford Nanopore Technologies - Overview
Oxford Nanopore Technologies - Product / Service
Oxford Nanopore Technologies - Key offerings
SWOT
14.14 Pacific Biosciences Inc.
Pacific Biosciences Inc. - Overview
Pacific Biosciences Inc. - Product / Service
Pacific Biosciences Inc. - Key news
Pacific Biosciences Inc. - Key offerings
SWOT
14.15 QIAGEN N.V.
QIAGEN N.V. - Overview
QIAGEN N.V. - Product / Service
QIAGEN N.V. - Key news
QIAGEN N.V. - Key offerings
SWOT
14.16 Revvity Inc.
Revvity Inc. - Overview
Revvity Inc. - Business segments
Revvity Inc. - Key offerings
Revvity Inc. - Segment focus
SWOT
14.17 Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. - Overview
Thermo Fisher Scientific Inc. - Business segments
Thermo Fisher Scientific Inc. - Key news
Thermo Fisher Scientific Inc. - Key offerings
Thermo Fisher Scientific Inc. - Segment focus
SWOT
14.18 Twist Bioscience Corp.
Twist Bioscience Corp. - Overview
Twist Bioscience Corp. - Product / Service
Twist Bioscience Corp. - Key offerings
SWOT
15 Appendix
15 Appendix
15.1 Scope of the report
Market definition
Objectives
Notes and caveats
15.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
15.3 Currency conversion rates for US$
Currency conversion rates for US$
15.4 Research methodology
Research methodology
15.5 Data procurement
Information sources
15.6 Data validation
Data validation
15.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
15.8 Data synthesis
Data synthesis
15.9 360 degree market analysis
360 degree market analysis
15.10 List of abbreviations
List of abbreviations
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Country Market Characteristics
Exhibits4: Executive Summary - Chart on Market Segmentation by Application
Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits6: Executive Summary - Chart on Market Segmentation by Solution
Exhibits7: Executive Summary - Chart on Company Market Positioning
Exhibits8: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits9: Overview on criticality of inputs and factors of differentiation
Exhibits10: Overview on factors of disruption
Exhibits11: Impact of drivers and challenges in 2025 and 2030
Exhibits12: Chart on Parent Market
Exhibits13: Data Table on - Parent Market
Exhibits14: Chart on Market characteristics analysis
Exhibits15: Chart on Value chain analysis
Exhibits16: Data Table on Offerings of companies included in the market definition
Exhibits17: Market segments
Exhibits18: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibits19: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibits20: Chart on US: Year-over-year growth 2025-2030 (%)
Exhibits21: Data Table on US: Year-over-year growth 2025-2030 (%)
Exhibits22: Historic Market Size - Data Table on Genomics Market in US 2020 - 2024 ($ million)
Exhibits23: Historic Market Size - Application Segment 2020 - 2024 ($ million)
Exhibits24: Historic Market Size - End-user Segment 2020 - 2024 ($ million)
Exhibits25: Historic Market Size - Solution Segment 2020 - 2024 ($ million)
Exhibits26: Five forces analysis - Comparison between 2025 and 2030
Exhibits27: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibits28: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibits29: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibits30: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibits31: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibits32: Chart on Market condition - Five forces 2025 and 2030
Exhibits33: Chart on Application - Market share 2025-2030 (%)
Exhibits34: Data Table on Application - Market share 2025-2030 (%)
Exhibits35: Chart on Comparison by Application
Exhibits36: Data Table on Comparison by Application
Exhibits37: Chart on Diagnostics - Market size and forecast 2025-2030 ($ million)
Exhibits38: Data Table on Diagnostics - Market size and forecast 2025-2030 ($ million)
Exhibits39: Chart on Diagnostics - Year-over-year growth 2025-2030 (%)
Exhibits40: Data Table on Diagnostics - Year-over-year growth 2025-2030 (%)
Exhibits41: Chart on Drug discovery - Market size and forecast 2025-2030 ($ million)
Exhibits42: Data Table on Drug discovery - Market size and forecast 2025-2030 ($ million)
Exhibits43: Chart on Drug discovery - Year-over-year growth 2025-2030 (%)
Exhibits44: Data Table on Drug discovery - Year-over-year growth 2025-2030 (%)
Exhibits45: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibits46: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibits47: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibits48: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibits49: Market opportunity by Application ($ million)

Search Inside Report

How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.